Stocks · Korea 225220 KOSDAQ

Genolution

1,401원 -2.03% Market cap 269억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR0.37x
EPS0 KRW
BPS3,786 KRW
ROE-14.48%
DPS0 KRW

Returns and 52-week range

1W-3.58%
1M+3.62%
3M+4.16%
6M-23.27%
1Y-41.13%
YTD-27.33%
52W high2,400원
52W low957원
From 52W high-41.62%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
202471억-92억-72억-128.4%
202594억-86억-126억-91.9%
Quarterly
2024 4Q21억-21억-16억-97.7%
2025 1Q21억-25억-23억-120.1%
2025 2Q29억-17억-37억-58.8%
2025 3Q21억-24억-13억-117.9%
2025 4Q24억-20억-53억-84.8%
2026 1Q25억-14억4억-55.6%

Company

CEO김기옥, 김민이(공동대표이사)
Founded2006-02-20
Fiscal year end12
Address: 서울특별시 강서구 마곡중앙8로3길 63 (주)제놀루션

Peers in the same sector

CompanyMarket capP/EP/B1M
티디에스팜310억6.930.69-3.78%
샤페론252억—1.02+6.67%
비씨월드제약324억—0.43-0.16%
에이프로젠바이오로직스250억—0.10-10.83%
고려제약353억5.330.42-8.29%
대성미생물229억38.410.65-3.37%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.